Cipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in India Medical Dialogues Bureau18 Oct 2019 8:20 AM GMTMumbai: Cipla Limited announces the acquisition of a novel and patented anti-infective product, Elores, from Venus Remedies Limited ("VRL") for the...
Cipla gets 12 USFDA observations for Goa facility Medical Dialogues Bureau30 Sep 2019 9:45 AM GMT"The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019,"...
Cipla launches skin treatment Daptomycin Injection in US Medical Dialogues Bureau27 Sep 2019 8:23 AM GMTDrug firm Cipla on Wednesday said it has launched Daptomycin Injection, used for treating complicated skin infections, in the US market. Daptomycin...
Cipla, B J Wadia Hospital enter partnership to set up paediatric palliative care unit Medical Dialogues Bureau7 Sep 2019 4:10 AM GMTCipla Foundation strongly believes that palliative care focuses on providing relief from symptoms and stress of illness at any point, yet most...
DOP junks Cipla plea to refix MRP of Tafmune–EM Farhat Nasim2 Sep 2019 11:04 AM GMTNew Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...
AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business Farhat Nasim31 Aug 2019 9:05 AM GMTNew Delhi: A lobby of 8.5 lakh chemists across the country is planning to boycott the products manufactured by Cipla if the company enters the e...
NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details Farhat Nasim16 Aug 2019 10:31 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors Farhat Nasim30 July 2019 8:38 AM GMTNew Delhi: The patent protection of blockbuster anti-diabetic drug Vildagliptin manufactured by the Swiss drugmaker, Novartis, will soon expire on...
NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister Medical Dialogues Bureau24 July 2019 6:46 AM GMTNPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details Farhat Nasim27 Jun 2019 10:37 AM GMTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA Meghna A Singhania23 Jun 2019 11:27 AM GMTNew Delhi: Allowing the review petition of Zydus Healthcare Limited regarding price fixation of Tiotropium Inhalation (MDI) 9 mcg/dose, the Department...
Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea Farhat Nasim16 Jun 2019 6:14 AM GMTNew Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority...